Skip to main content
Clinical Trials/CTRI/2022/01/039232
CTRI/2022/01/039232
Completed
未知

A Prospective exploratory clinical trial to assess safety and efficacy of WMS01 in management of weight in healthy adults. - Nil

aturedge Beverages Pvt Ltd0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
aturedge Beverages Pvt Ltd
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 23, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
aturedge Beverages Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Obese patients (male/female and aged between 20\-45 yrs.)
  • BMI between 30 \- 40 kg/m2
  • Subjects with or without comorbidities, if comorbidity exists should be on stable prescription and with the following criteria\- Hypertension (140/90 mmHg on prescription), Type 2 DM (HbA1C \<\= 7\.5 on prescription)
  • Willing to provide consent
  • Willing for follow up

Exclusion Criteria

  • Subjects with any acute illness requiring immediate medical care.
  • Subjects with Type I DM/Complicated cardiovascular diseases / HbA1C \>\= 7\.5\. / History of TIA, Cerebrovascular accident, stroke or any revascularization.
  • Known subjects of hepatic failure/inflammation.
  • Pregnant, breast feeding or planning to become pregnant during the study.
  • Any other condition which proves subject unfit for the study participation

Outcomes

Primary Outcomes

Not specified

Similar Trials